HMGCR (HMG-CoA Reductase)

HMGCR

Rate-limiting enzyme in the mevalonate pathway of cholesterol biosynthesis.

Funktion

Catalyzes conversion of HMG-CoA to mevalonate. Statins competitively inhibit this enzyme, reducing hepatic cholesterol synthesis.

Arzneimittel, die auf dieses Target wirken

Arzneimittel Wirkung Primär
Atorvastatin Inhibitor Ja
Simvastatin Inhibitor Ja
Rosuvastatin Inhibitor Ja
Pravastatin Inhibitor Ja

Related Targets